GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
684,206
Share change
+27,975
Total reported value
$607,071
Price per share
$0.88
Number of holders
8
Value change
+$24,903
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q1 2019

As of 31 Mar 2019, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 684,206 shares. The largest 8 holders included RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, Alpine Group USVI, LLC, Cambridge Investment Research Advisors, Inc., UBS Group AG, Cutler Group LP, and BREWIN DOLPHIN Ltd. This page lists 8 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.